Mihm, Alexandra Evaun http://orcid.org/0000-0001-8326-2521
Hicklin, Harry Eugene http://orcid.org/0000-0002-0074-0506
Cunha, Alexandra Lee http://orcid.org/0000-0002-5299-6124
Nisly, Sarah Anne http://orcid.org/0000-0002-1370-4694
Davis, Kyle Andrew http://orcid.org/0000-0002-9805-575X
Article History
Received: 26 May 2021
Accepted: 3 June 2021
First Online: 24 June 2021
Declarations
:
: Kyle A Davis is currently employed by United Therapeutics Corporation. However, at the time of project development, research analysis, and manuscript writing, he was an employee of Wake Forest Baptist Medical Center, where the research was conducted.
: This research qualified for expedited review under the Federal Regulations [45CFR46.110]. This research met the criteria for a waiver of consent entirely according to 45 CFR 46(d) and met the criteria for a waiver of HIPAA authorization according to 45 CFR 164.512.
: This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Human Investigation Committee (IRB) of Wake Forest University approved this study.
: This research met the criteria for a waiver of consent entirely according to 45 CFR 46(d). Consequently, for this type of study, no informed consent was required.
: This research met the criteria for a waiver of consent entirely according to 45 CFR 46(d) and met the criteria for a waiver of HIPAA authorization according to 45 CFR 164.512. Consequently, consent to participate and consent for publication were not obtained.